|
Market Closed -
Nasdaq
21:00:00 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 209.15 USD | -0.32% |
|
+0.98% | +18.84% |
| 08-13 | Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300 | MT |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
Chart: Technical Analysis
Stock exchange
Nasdaq
BIIB 209.15 $
-0.32%
129M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| BIIB | 209.15USD | -0.32% | 129M $ | |
CBOE
| BIIB | 209.00USD | -0.38% | 2.74M $ | |
|
Tradegate
| IDP | 180.74EUR | -0.31% | 54.04K € | |
|
Deutsche Boerse AG
| IDP | 179.12EUR | -0.29% | 17.91K € | |
|
Mexican S.E.
| BIIB * | 3,678.00MXN | +0.59% | 213K $ | |
|
Wiener Boerse
| BIIB | 180.84EUR | -0.11% | 542.52 € | |
|
Xetra
| IDP | 180.92EUR | +0.01% | 361.84 € | |
|
Boerse Muenchen
| IDP | 180.48EUR | -0.55% | 180.48 € | |
|
Kazakhstan S.E.
| BIIB_KZ | 180.00USD | -11.76% | 180 $ | |
|
Swiss Exchange
| BIIB | 169.98CHF | +1.74% | 0 CHF | |
|
Börse Stuttgart
| IDP | 180.82EUR | -0.26% | 0 € | |
|
Santiago S.E.
| BIIB | 207.13USD | 0.00% | 0 $ | |
|
Borsa Italiana
| 1BIIB | 181.04EUR | -0.96% | 0 € | |
|
Santiago S.E.
| BIIBCL | 189,790.00CLP | 0.00% | 0 $ | |
|
Swiss Exchange
| BIIB | 209.20USD | +1.31% | 0 $ | |
|
CBOE
| 164.48EUR | -.--% | 0 € | ||
Sao Paulo
| BIIB34 | 172.75BRL | +1.41% | 3.97K R$ | |
Buenos Aires S.E.
| BIIB | 25,360.00ARS | -1.40% | 1.5M $ | |
|
Buenos Aires S.E.
| BIIBD | 16.82USD | -0.06% | 67.28 $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 210.65 | 216.63 | 216.12 |
| Spread/Res. | -0.71% | -3.45% | -3.23% |
| Spread/Supp. | +3.63% | +21.36% | +20.92% |
| Support | 201.82 | 172.34 | 172.97 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
